GLP-1 Leads to Similar Cognitive Outcomes as Other Diabetes Drugs, Trial Data Show

(MedPage Today) — Cognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the GRADE clinical trial showed.
Cognitive performance at 4.1 years of follow-up was similar in participants…

Source link : https://www.medpagetoday.com/neurology/dementia/115661

Author :

Publish date : 2025-05-19 21:31:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

GLP-1 Leads to Similar Cognitive Outcomes as Other Diabetes Drugs, Trial Data Show

Best Intensive Care Unit Sedative? Head-to-Head Trial Weighs In

Routine Antibiotics Appear to Hold No Benefit in Non-Severe COVID-19

Related Posts

JAK Inhibitors Raise Venous Thromboembolism Risk in AD

Here’s Who Made This Year’s List of Top Hospitals

At Least 60% of Liver Cancers Tied to Preventable Risk Factors

Delivering the World’s Most Premature Baby, as Told by the Medical Team

Vaping Up Slightly While Heavy Alcohol Use Down a Little, SAMHSA Report Finds

HTO May Slow Knee OA Progression in Bowlegged Patients

JAK Inhibitors Raise Venous Thromboembolism Risk in AD

Here’s Who Made This Year’s List of Top Hospitals

At Least 60% of Liver Cancers Tied to Preventable Risk Factors

Delivering the World’s Most Premature Baby, as Told by the Medical Team

Vaping Up Slightly While Heavy Alcohol Use Down a Little, SAMHSA Report Finds

HTO May Slow Knee OA Progression in Bowlegged Patients

Realignment Surgery Definitely Helps in Knee OA, Trial Indicates

RFK Jr. Says He’s Going to Overhaul Vaccine Injury Program

Categories

Archives